AI assistant
10x Genomics, Inc. — Director's Dealing 2021
Sep 21, 2021
31830_dirs_2021-09-20_9ad62479-f4ac-406b-a7f3-e46c507ebc20.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2021-09-16
Reporting Person: STUELPNAGEL JOHN R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-16 | Class A Common Stock | S | 700 | $154.4529 | Disposed | 375916 | Direct |
| 2021-09-16 | Class A Common Stock | S | 1500 | $155.689 | Disposed | 374416 | Direct |
| 2021-09-16 | Class A Common Stock | S | 1631 | $156.7217 | Disposed | 372785 | Direct |
| 2021-09-16 | Class A Common Stock | S | 1169 | $157.7455 | Disposed | 371616 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
F2: This transaction was executed in multiple trades at prices ranging from $154.085 to $154.97. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3: This transaction was executed in multiple trades at prices ranging from $155.19 to $156.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4: This transaction was executed in multiple trades at prices ranging from $156.25 to $157.24. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5: This transaction was executed in multiple trades at prices ranging from $157.26 to $158.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.